{"schema_version":"1","generated_at":"2026-10-28T13:57:25.075Z","data_as_of":"2026-10-26","url":"https://www.findmykol.com/kol/trent-hummel","json_url":"https://www.findmykol.com/kol/trent-hummel/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"trent-hummel","name":"Trent Hummel","credential":"MD","title":"Co-Medical Director, Brain Tumor Center","specialty":"Hematology / Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Neuro-Oncology","therapeutic_areas":["Neuro-Oncology","Leukemia","Melanoma"],"institution":"Cincinnati Children's Hospital Medical Center","institution_url":"https://www.findmykol.com/institution/cincinnati-children-s-hospital-medical-center","city":"Cincinnati","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1225155831","orcid":"0009-0008-4911-9615","openalex":"A5045064484"},"summary":"Trent Hummel is Co-Medical Director, Brain Tumor Center at Cincinnati Children's Hospital Medical Center. OpenAlex indexes 132 publications with 1,784 citations (h-index 20); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.","overview":{"text":"Trent Hummel, M.D., is Co-Medical Director, Brain Tumor Center at Cincinnati Children's Hospital Medical Center. The public record shows 132 publications with 1,784 citations (h-index 20), centered on Glioma Diagnosis and Treatment, Cancer Genomics and Diagnostics, Neurofibromatosis and Schwannoma Cases. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 2 companies.","bullets":["Most recent indexed publication: 2026 · Radiology. Artificial intelligence","Top research focus: Glioma Diagnosis and Treatment","5 registered trials on ClinicalTrials.gov","Open Payments reporting from 2 companies"],"generated_at":"2026-10-27"},"focus":{"indications":[{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":3,"topics":1,"strength":10},{"label":"Glioma","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Meningioma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Ependymoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Teratoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Endodermal Sinus Tumor","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Choriocarcinoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Germinoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Neoplasms, Germ Cell and Embryonal","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Neurofibromatoses","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Neurofibroma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Fibroma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Astrocytoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Oligodendroglioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Medulloblastoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neuroectodermal Tumors, Primitive","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Rhabdoid Tumor","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Paraganglioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Craniopharyngioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Pinealoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Paraganglioma, Extra-Adrenal","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Pica","therapeutic_area":"Psychiatry","trials":1,"topics":0,"strength":3},{"label":"Diffuse Intrinsic Pontine Glioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Carcinoma, Embryonal","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neurofibromatosis 1","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neuroma, Acoustic","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neurofibromatosis 2","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neurilemmoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Melanoma","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1}],"research_topics":["Glioma Diagnosis and Treatment","Cancer Genomics and Diagnostics","Neurofibromatosis and Schwannoma Cases","Acute Lymphoblastic Leukemia research","Melanoma and MAPK Pathways"],"drugs_studied":{"total":1,"shown":1,"withheld":0,"rows":[{"name":"Ojemda","generic":"Tovorafenib","trials":0,"payments":1,"publications":0,"mentions":1}]},"works_with":{"total":6,"shown":3,"withheld":3,"rows":[{"name":"Blueprint Medicines Corporation","trials":0,"payments":7,"mentions":7},{"name":"Children's Hospital Medical Center, Cincinnati","trials":2,"payments":0,"mentions":2},{"name":"Children's Oncology Group","trials":1,"payments":0,"mentions":1}]}},"scholarship":{"works_count":132,"cited_by_count":1784,"h_index":20,"i10_index":33,"pubmed_count":1,"latest_activity_year":2026,"source":"works"},"trials":{"count":5,"shown":3,"withheld":2,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT06541847","title":"A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Healx Limited","source_url":"https://clinicaltrials.gov/study/NCT06541847","trial_url":"https://www.findmykol.com/trial/NCT06541847"},{"nct":"NCT04684368","title":"A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Children's Oncology Group","source_url":"https://clinicaltrials.gov/study/NCT04684368","trial_url":"https://www.findmykol.com/trial/NCT04684368"},{"nct":"NCT03101813","title":"International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository","status":"RECRUITING","role":"Investigator","sponsor":"Children's Hospital Medical Center, Cincinnati","source_url":"https://clinicaltrials.gov/study/NCT03101813","trial_url":"https://www.findmykol.com/trial/NCT03101813"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2022,"last":2025},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"Day One Biopharmaceuticals","program_year":2025,"amount_usd":4160,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1225155831"},{"payer":"Blueprint Medicines Corporation","program_year":2024,"amount_usd":3157,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1225155831"},{"payer":"Blueprint Medicines Corporation","program_year":2023,"amount_usd":3653,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1225155831"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1225155831","source":"payments"},"prescribing":{"data_year":2021,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":1,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":100,"drugs":[{"name":"Mekinist","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":7,"years":{"first":2011,"last":2025},"societies":["ASCO"],"shown":3,"withheld":4,"rows":[{"title":"A phase 1 study to evaluate the safety and tolerability of BXQ-350, a novel sphingolipid metabolism modulator, in pediatric diffuse intrinsic pontine glioma and diffuse midline glioma.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.e14044","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.e14044","status":"verified"},{"title":"Efficacy and safety results from a phase I/IIa study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed refractory low-grade glioma.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2018,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.10506","source_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.10506","status":"verified"},{"title":"Next generation sequencing (NGS) to identify targetable recurring mutations and exceptional responders in relapsed and high-risk childhood and adolescent/young adult (AYA) malignancies.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2015,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.11011","source_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.11011","status":"verified"}],"source":"congress"},"publications":{"total":1,"shown":1,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Multi-Institutional Annotated Multiparametric MRI Dataset of Pediatric High-Grade Gliomas.","year":2026,"journal":"Radiology. Artificial intelligence","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42053414/","status":"verified"}],"most_cited":{"total":132,"shown":5,"withheld":127,"rows":[{"title":"Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis","year":2012,"cited_by_count":319,"type":"article","source_url":"https://doi.org/10.1093/neuonc/nos076"},{"title":"Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics","year":2016,"cited_by_count":199,"type":"article","source_url":"https://doi.org/10.1186/s40478-015-0269-0"},{"title":"The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1","year":2015,"cited_by_count":108,"type":"article","source_url":"https://doi.org/10.1016/j.jpeds.2015.07.001"},{"title":"A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study","year":2016,"cited_by_count":106,"type":"article","source_url":"https://doi.org/10.1007/s11060-016-2189-7"},{"title":"A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation–Positive Solid Tumors","year":2019,"cited_by_count":97,"type":"article","source_url":"https://doi.org/10.1158/1078-0432.ccr-17-3572"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Maryam Fouladi","coauthored_works":47,"profile_url":"https://www.findmykol.com/kol/maryam-fouladi"},{"name":"Peter M K de Blank","coauthored_works":36},{"name":"Ralph Salloum","coauthored_works":34,"profile_url":"https://www.findmykol.com/kol/ralph-salloum"}],"source":"works"},"presence":{"owned_accounts":{"total":2,"shown":2,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/trent-hummel-md","status":"verified"},{"platform":"other","url":"https://www.cincinnatichildrens.org/bio/h/trent-hummel","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":3,"shown":3,"rows":[{"value":"Fellowship, Pediatric Hematology/Oncology, Cincinnati Children's Hospital Medical Center, 2007","source_url":"https://www.cincinnatichildrens.org/bio/h/trent-hummel","status":"verified","collected_at":"2026-10-26"},{"value":"Residency, Children's Hospital Medical Center of Akron, 2004","source_url":"https://www.cincinnatichildrens.org/bio/h/trent-hummel","status":"verified","collected_at":"2026-10-26"},{"value":"MD, University of Cincinnati College of Medicine, 2001","source_url":"https://www.cincinnatichildrens.org/bio/h/trent-hummel","status":"verified","collected_at":"2026-10-26"}]},"roles":{"total":1,"shown":1,"rows":[{"value":"Member, Central Nervous System (Brain Tumor) Committee, Children's Oncology Group","source_url":"https://www.cincinnatichildrens.org/bio/h/trent-hummel","status":"verified","collected_at":"2026-10-26"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"University of Cincinnati Department of Pediatrics (listed as Professor)","source_url":"https://www.cincinnatichildrens.org/bio/h/trent-hummel","status":"verified","collected_at":"2026-10-26"}]},"public_positions":{"total":3,"shown":2,"rows":[{"value":"Co-principal investigator, Pediatric Brain Tumor Consortium (PBTC) at Cincinnati Children's","source_url":"https://www.cincinnatichildrens.org/bio/h/trent-hummel","status":"verified","collected_at":"2026-10-26"},{"value":"Fellowship Director, Neuro-Oncology Fellowship, Cincinnati Children's","source_url":"https://www.cincinnatichildrens.org/education/clinical/fellowship/neuro-oncology/team","status":"verified","collected_at":"2026-10-26"}]}},"similar":[{"name":"Andrea Beaton","slug":"andrea-beaton","institution":"Cincinnati Children's Hospital Medical Center","specialty":"Pediatric Cardiology","url":"https://www.findmykol.com/kol/andrea-beaton","json_url":"https://www.findmykol.com/kol/andrea-beaton/profile.json"},{"name":"Prasad Devarajan","slug":"prasad-devarajan","institution":"Cincinnati Children's Hospital Medical Center","specialty":"Pediatric Nephrology","url":"https://www.findmykol.com/kol/prasad-devarajan","json_url":"https://www.findmykol.com/kol/prasad-devarajan/profile.json"},{"name":"Stuart Goldstein","slug":"stuart-goldstein","institution":"Cincinnati Children's Hospital Medical Center","specialty":"Pediatric Nephrology","url":"https://www.findmykol.com/kol/stuart-goldstein","json_url":"https://www.findmykol.com/kol/stuart-goldstein/profile.json"},{"name":"Tracy Glauser","slug":"tracy-glauser","institution":"Cincinnati Children's Hospital Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/tracy-glauser","json_url":"https://www.findmykol.com/kol/tracy-glauser/profile.json"},{"name":"Guy McKhann","slug":"guy-mckhann","institution":"Emory University School of Medicine","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/guy-mckhann","json_url":"https://www.findmykol.com/kol/guy-mckhann/profile.json"},{"name":"Patrick Wen","slug":"patrick-wen","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/patrick-wen","json_url":"https://www.findmykol.com/kol/patrick-wen/profile.json"},{"name":"Minesh Mehta","slug":"minesh-mehta","institution":"Florida International University Herbert Wertheim College of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/minesh-mehta","json_url":"https://www.findmykol.com/kol/minesh-mehta/profile.json"},{"name":"Timothy Cloughesy","slug":"timothy-cloughesy","institution":"Ronald Reagan UCLA Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/timothy-cloughesy","json_url":"https://www.findmykol.com/kol/timothy-cloughesy/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"payments":1,"congress":4,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-26"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-26"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2022 to 2025","collected_at":"2026-10-26"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2021},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-26"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-26"}},"methodology_url":"https://www.findmykol.com/about#methodology"}